Cholestrol-reducing agent containing an n-3 fatty acid
OwnerBernd Haber, Stephan Hausmanns +1inventors
InventorsBernd Haber, Stephan Hausmanns, Matthias Ruesing
Life of this patent
Estimating the term…
Abstract
This invention relates to a cholesterol-reducing active substance combination containing at least one cholesterol-reducing carob product, particularly water-insoluble carob fibers, at least one n-3 fatty acid and at least one cholesterol-reducing active substance. The invention also relates to a method for producing active substance combinations of this type and to the use thereof.
Claims24
A cholesterol-reducing agent comprising from 1 to 15 g of at least one carob product, n-3 fatty acid comprising at least DHA and at least one cholesterol-reducing active compound, the cholesterol-reducing active compound being selected from one or more of the following substances:
- statins, inhibitors of bile acid resorption, cholesterol absorption inhibitors, fibrates, nicotinic acid derivatives, bile acid sequestrants, phytosterols, plant stanols and also cholesterol-reducing plant extracts, said agent providing a greater reduction in cholesterol level than the sum of the effects when the carob product, n-3 fatty acid or cholesterol-reducing active compound arc administered alone,
- said agent further providing a reduction of total cholesterol of at least 10% when said n-3 fatty acid consists of DHA alone.
A cholesterol-reducing combination preparation comprising from 1 to 15 g of at least one carob product, n-3 fatty acid comprising at least DHA and at least one cholesterol-reducing active compound in separate administration forms, said cholesterol-reducing combination preparation providing a reduction in total cholesterol of at least 10% when said n-3 fatty acid consists of DHA alone.
(canceled)
A cholesterol-reducing agent comprising at least one carob product, at least one n-3 fatty acid and at least one cholesterol-reducing active compound,
- said n-3 fatty acid consisting of one or more of:
- all-cis-9,12,15-octadecatrienoic acid (ALA), all-cis-6,9,12,15 -octadecatetraenoic acid, all-cis-11,14,17-eicosatrienoic acid, all-cis-13,16,19-docosatrienoic acid, all-cis-7,10,13,16,19-docosapentaenoic acid (DPA) and all-cis-4,7,10,13,16, 19-docosahexaenoic acid (DHA),
- said cholesterol-reducing active compound being selected from one or more of the following substances:
- statins, inhibitors of bile acid resorption, cholesterol absorption inhibitors, fibrates, nicotinic acid derivatives, bile acid sequestrants, phytosterols, plant stanols and also cholesterol-reducing plant extracts,
- wherein said agent provides a greater reduction in cholesterol level than the sum of the effects when the carob product, n-3 fatty acid or cholesterol-reducing active compound are administered alone.
Dependencies are inferred from the claim text.